Rise Life Science Corp (RLSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 08-2021 | 05-2021 | 02-2021 | 11-2020 | 08-2020 | |
| Sales | 0 | 0 | 0 | 1 | 3 |
| Cost of Goods | 0 | 0 | 0 | 1 | 2 |
| Gross Profit | 0 | 0 | 0 | 0 | 2 |
| Operating Expenses | 177 | 355 | 19 | 159 | 222 |
| Operating Income | -177 | -355 | -19 | -159 | -220 |
| Interest Expense | 122 | 21 | 132 | 296 | 404 |
| Other Income | 217 | 5,260 | 133 | -616 | -221 |
| Pre-tax Income | -82 | 4,884 | -18 | -1,071 | -846 |
| Net Income Continuous | -82 | 4,884 | -18 | -1,071 | -846 |
| Net Income | $-82 | $4,884 | $-18 | $-1,071 | $-846 |
| EPS Basic Total Ops | 0.00 | 0.60 | 0.00 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | 0.00 | 0.60 | 0.00 | -0.10 | -0.10 |
| EPS Diluted Total Ops | 0.00 | 0.60 | 0.00 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | 0.00 | 0.60 | 0.00 | -0.10 | -0.10 |
| EBITDA(a) | $40 | $4,905 | $119 | $-759 | $-424 |